TARS
Tarsus Pharmaceuticals Inc
78.60$
+2.5%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | +2,341.0% | +194.9% | +4.0% | +27.4% | +16.5% | +42.0% | +49.1% | |
| – | +2,335.2% | +194.1% | +3.1% | +28.1% | +13.6% | +39.3% | +46.6% | |
| – | +2,360.8% | +190.1% | +1.9% | -58.2% | +213.9% | -57.8% | +93.7% | |
| – | +2,360.8% | +190.1% | +2.2% | +26.3% | +4.8% | +28.1% | +43.2% | |
| – | +800.0% | -44.4% | +360.0% | +3,793.5% | +394.5% | +171.3% | +81.3% | |
| – | – | – | – | -97.3% | -34.8% | -15.7% | +66.9% | |
| – | +4,566.7% | +341.4% | -38.9% | +26.8% | – | – | – | |
| – | – | – | – | – | – | +115.3% | -11.5% | |
| – | +1,618.4% | -90.7% | +103.2% | +187.1% | +95.9% | +122.6% | +43.5% | |
| – | +357.5% | +557.8% | +113.1% | +34.4% | +139.4% | +118.2% | +68.3% | |
| – | – | +340.6% | +363.1% | -44.8% | -44.8% | +52.8% | – | |
| – | +160.6% | +390.6% | +27.7% | +92.5% | +223.2% | +56.1% | -40.9% | |
| – | – | – | – | – | +53.4% | +140.9% | +0.8% | |
| – | – | – | +0.5% | +15.7% | +2.1% | +14.0% | +53.0% | |
| – | – | – | – | – | – | – | – | |
| – | +355.3% | +4.2% | +1.1% | +19.8% | +19.3% | +28.0% | +11.1% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.